Finanzen von InflaRx NV (IFRX)IFRXInflaRx NV

Evaluating the bottom line, InflaRx NV maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -38.52%, provide a clear picture of how effectively IFRX converts its operational activities into shareholder value.

In the context of the broader market, IFRX competes directly with industry leaders such as CRDL and DMAC. With a market capitalization of $300.63M, it holds a significant position in the sector. When comparing efficiency, IFRX's gross margin of N/A stands against CRDL's N/A and DMAC's N/A. Such benchmarking helps identify whether InflaRx NV is trading at a premium or discount relative to its financial performance.

InflaRx has faced challenges with revenue, reporting total revenue of only 123,819 EUR in Q3 2024, and negative net income across multiple quarters. However, the current ratio is strong at 8.22, indicating good liquidity.